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Abstract: This review will focus on the basic mechanisms of the peripheral chemoreceptors elicited by studies on mature
chemoreceptors and on the alterations observed in these structures related to sudden infant death. The integrated response
of the peripheral chemoreceptors consists of the transduction of alterations in the chemical milieu, regulating the
temperature of their environment to alterations in cardiovascular and respiratory performance. Over the years, much has
been written about the relative importance of the carotid and aortic bodies in the peripheral chemoreceptor response, and it
is therefore worthwhile to consider the current state-of-the-art on that issue. Several lines of evidence have suggested that
abnormalities in chemoreception may play a role in central hypoventilation syndromes. The sudden infant death syndrome
(SIDS) involves a failure of respiration and affects infants in their early postnatal months. Unstable respiratory activity
during sleep, prolonged sleep apnea, and oropharyngeal/laryngeal dysfunction induced by liquid stimulation of the upper
airways have been postulated to be implicated in its genesis. It has also been found that in comparison with normal
infants, infants suffering from the “aborted syndrome” (near-miss infants) are hypoventilated during quiet sleep, and have
an impaired ventilatory response to carbon dioxide breathing.
Keywords: Peripheral chemoreceptors, aorticopulmonary paraganglia, carotid body, SIDS, stillbirth.
INTRODUCTION
The efficient uptake and delivery of oxygen and removal
of carbon dioxide are critical to healthy survival, and a host
of mechanisms are therefore deputed to achieving this goal.
After birth, these mechanisms are directed at both the
cardiovascular and pulmonary systems, whereas prior to
birth the lungs play no role in gas exchange. Thus, it is likely
that any mechanism that regulates the oxygen and acid-base
status will function quite differently in the fetus, and that
birth is associated with a sudden and dramatic alteration in
its function. The mechanism involved consists of chemorece-
ption and transduction, a process whereby alterations in
oxygen, carbon dioxide and acid-base status are sensed by
receptors, which then invoke a variety of responses to
mitigate these alterations. Although innumerable studies
have been performed since De Castro [1,2] and Heymans
and coworkers [3] first began the study of peripheral
chemoreceptor function, and Barcroft [4] then extended
these studies to the fetus, much of the issue is still
speculative and should be considered as an aid to focusing
future studies rather than as a repository of fact. In his
presentation to the International Society for Arterial
Chemoreception in 1991, Eyzaguirre [5] summed up the
current understanding of chemoreception most aptly: “this
field will remain puzzling until more information on
different variables is available.”
This review will focus firstly on the basic mechanisms of
the peripheral chemoreceptors elicited by studies on mature
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chemoreceptors. It then will address the alterations observed
in these structures related to sudden infant death.
CHEMORECEPTION: BASIC MECHANISMS
Anatomy
The components of chemoreception include peripheral
and central neuroreceptors, neural afferents, and
neurohumoral effectors that alter both pulmonary
performance (rate and depth of breathing) and cardiovascular
performance (ventricular performance, regional blood flows
and perfusion pressures). The peripheral chemoreceptors are
composed of glomera, or tissues with extensive and
convoluted capillary networks. Although there is glomus
tissue in a variety of sites throughout the body, the most
important are the carotid body, located at the junction of the
external and internal carotid arteries, and the aortic bodies
(also known as aorticopulmonary paraganglia), a more
diffuse group of small glomera primarily situated in the
aortic arch. In addition to the network of capillaries, the
glomus consists of three cell types: the type I, or glomus cell,
thought to be the true receptor, is predominant; the type II, or
sustentacular cell, functions as the support cell and features
extensive glial-like projections; and few ganglion cells are
present, which may be either sympathetic or parasympathetic
[6]. The carotid body is innervated by the carotid (sinus)
nerve, which is a branch of the glossopharyngeal nerve,
while the aortic bodies are innervated by the aortic nerve, a
branch of the vagus. These nerves carry autonomic traffic for
both the chemoreceptors and the adjacent baroreceptors. In
the glomera, they branch extensively, innervating 10-20
glomus cells, which form the sensory unit [7]. Each fiber
may distribute both afferent or post-synaptic nerve endings,
the junctions of which are characterized by the secretory
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vesicles residing in the glomus cells and efferent or pre-
synaptic nerve endings, where the secretory vesicles are
directly resident. Efferent fibers may modulate receptor fun-
ction by secreting neuromodulators which alter glomus cell
function, or by altering blood flow to the sensory unit, which
in turn alters the stimulus to the receptor discharge [7].
The central chemoreceptor components are less well
described. Over the past decade, an increasing number of
central nuclei, in addition to the ventrolateral medulla, have
been proposed to contain putative central chemoreceptors,
including the solitary complex, the medullary raphe, the
nucleus ambiguus, the locus coeruleus, and the
hypothalamus [8]. Recent pathological investigations of
sudden fetal deaths after the 25th week of gestation
(stillbirths) have demonstrated frequent hypoplasia of the
arcuate nucleus, an important chemoreceptorial respiratory
center of the medullary ventral surface [9,10]. This had
previously been described in sudden infant deaths [11].
Further research is necessary and ongoing to identify any
links between abnormalities of the central and peripheral
chemoreceptor apparatus with central hypoventilation
syndromes, such as sleep apnea and sudden infant death
syndrome.
Integrated Physiology
The integrated response of the peripheral chemoreceptors
lies in the transduction of alterations in the chemical milieu,
regulating the tonicity, or the temperature of their
environment to alterations in cardiovascular and respiratory
performance [7]. Although the carotid chemoreceptors
respond to changes in both oxygen and acid-base status, the
aortic chemoreceptors are much more sensitive to oxygen,
and as such have been considered to have the physiological
function of oxygen sensors [12,13]. The sensory discharge
from both chemoreceptors reaches the respiratory and
cardiovascular centers in the brainstem, and invokes
increases in ventilation, heart rate and cardiac output, as well
as peripheral vasoconstriction through autonomic pathways
and catecholamine release from the adrenal medulla.
Superimposed on the cardiorespiratory effects of the
peripheral chemoreceptors, there are the independent effects
of the baroreceptors and central chemoreceptors [6]. The
central chemoreceptors respond primarily to changes in
pCO2 and alter ventilation by direct effects on the respiratory
center, while the baroreceptors respond to changes in local
arterial pressure and alter regional blood flows by
sympathetic stimulation and secretions of various hormones,
such as ACTH, vasopressin and renin; these hormonal
responses are not apparently directly induced by
chemoreceptor activity [14].
Biological Mechanisms
The subcellular mechanisms of various components of
chemoreception and transduction have been extensively
studied over the past several years. The components can be
classified as follows: the sensory components, in which the
stimulus is perceived by the sensing organ as having
changed; the intracellular components, in which a series of
intracellular events then triggers the release of
neurotransmitters; the afferent neural components, in which
the neurotransmitters affect the sensory discharge of the
local fibers; the efferent neural components, which respond
to changes in sensory input with alterations in their activity;
and the cardiorespiratory components, which respond to
changes in the activity of the effector nerves with changes in
cardiac, vascular and respiratory performance [15].
The sensory components of the peripheral and central
chemoreceptors have been extensively studied, but although
a large body of information is now available, many data and
hypotheses are contradictory. It is not even entirely clear
which cells in the glomera comprise the sensory unit,
although it is now generally accepted that they are the type I
cells. The mechanisms underlying stimulation of the sensory
unit remain unclear. The discrepancy in the sensitivity of the
carotid and the aortic bodies to oxygen is explained in this
model: the carotid body is postulated to have very high blood
flow and oxygen metabolism, and thus to be insensitive to
modest changes in blood pressure or oxygen content,
whereas the aortic body, with its lower flow, may be very
sensitive to even modest changes in these variables [16,17].
This hypothesis is taken further to assume different roles for
these two main peripheral chemoreceptors: the sensitivity of
the aortic body to modest circulatory changes makes it well
suited to functioning as the monitor of the combined state of
respiratory oxygen uptake and cardiovascular oxygen
delivery [18], while the lack of sensitivity to changes in
pCO2 places it as the sensor of respiratory oxygen uptake
[17]. It is clear that a variety of chemicals are released by
chemoreceptor stimulation, including catecholamines,
acetylcholine, and neuropeptides, but the importance of each
in response to a given stimulus or even a given species is
uncertain [5]. Catecholamines, particularly dopamine, may
also play an important role as neurotransmitters [19].
Granules containing catecholamines are present in high
concentrations in the carotid body, particularly during
chronic hypoxia [20], and chemodectomas occur far more
commonly at high altitude [21]. Whatever may be the precise
mechanisms underlying neurotransmitter release and its
modulation, the release invokes a nerve-cell discharge which
ascends to the nucleus tractus solitarius and, via a change in
the frequency or profile of the discharge, elicits
cardiopulmonary reflexes.
Chemoreception in the Fetus
Perhaps more than any other vital activity, the
maintenance of adequate oxygen uptake and delivery differs
profoundly in fetal life in comparison with the means
adopted after birth. Oxygen uptake is dependent upon
adequate blood flow and gas exchange across the placenta,
arising from the descending aorta. Oxygen is delivered by
both ventricles: the inflow of oxygenated blood from the
umbilical circulation is partially delivered to the left
ventricle across an intracardiac shunt, the foramen ovale; and
the outflow of oxygenated blood from the right ventricle is
delivered to the systemic vascular bed across an extracardiac
shunt, the ductus arteriosus. It is not therefore surprising that
chemoreception must evoke very different cardiopulmonary
responses in the fetus. When the study of fetal
chemoreception began about fifty years ago, it was generally
believed that the absence of effective ventilation in utero
implied that chemoreception was of limited importance to
the fetus. It was long believed that dramatic maturation
Chemoreceptors and SIDS Current Cardiology Reviews, 2005, Vol. 1, No. 1    67
occurred in the perinatal period, allowing the newborn to
respond to hypoxia and hypercapnia by increasing
ventilatory effort. Although the sensory neurons which form
the afferent limb of the chemoreflex have been demonstrated
to be biochemically immature [22], it is becoming apparent,
however, that the chemoreceptor response is quite mature in
the late-term fetus [15].
After birth, the inhibition of continuous breathing is
immediately abolished and peripheral chemoreceptors
assume their major role in the regulation of breathing. It
would be logical to speculate that removal of the placental
factor is responsible [23]. Another hypothesis is that the
activity of the peripheral chemoreceptor, particularly the
carotid body, increases dramatically as blood flow decreases
[24], thereby overwhelming the inhibitory effects of the
lateral pons. However, a recent study has demonstrated that
in about a third of stillbirths there is congenital
hypodevelopment of both the lung and the arcuate
nucleus[25,26]. It was postulated that in these cases the
arcuate nucleus hypoplasia could exert a negative effect on
respiratory movements in utero and therefore on lung
development. These alterations support the hypothesis that
functional or structural abnormalities of components of the
vegetative nervous system that modulate fetal breathing lead
to disturbances in the development of the respiratory
apparatus, in particular pulmonary hypoplasia in stillbirth.
Over the years, much has been written about the relative
importance of the carotid and aortic bodies in the peripheral
chemoreceptor response of the fetus, and it is therefore
worthwhile to consider the current state-of-the-art on the
issue. Because the postnatal activity of the carotid body is
primarily directed toward maintaining adequate ventilation
via O2 and CO2 sensing and the aortic bodies are primarily
directed toward maintaining adequate oxygen delivery via O2
sensing, it was originally hypothesized that the aortic
chemoreceptors were much more important than the carotid
chemoreceptors in the fetus. Initial studies seemed to
confirm this hypothesis, suggesting that the aortic
chemoreceptors were largely responsible for the
cardiovascular response to hypoxia in late-gestation fetal
sheep [27]. The difference lies not in the activity of the
carotid chemoreceptor but in the ventilatory response to that
activity, which is suppressed by central inhibition of the
hypoxic ventilatory response prior to birth.
Several lines of evidence have suggested that
abnormalities in chemoreception may play a role in central
hypoventilation syndromes [9-11,28]. The sudden infant
death syndrome involves a failure of respiration and affects
infants in their early postnatal months. Unstable respiratory
activity during sleep, prolonged sleep apnea, and
oropharyngeal/laryngeal dysfunction induced by liquid
stimulation of the upper airways have been postulated to be
implicated in its genesis [29-31]. It has also been found that
in comparison with normal infants, infants suffering from the
"aborted syndrome” (near-miss infants) are hypoventilated
during quiet sleep, and have an impaired ventilatory
response to carbon dioxide breathing during quiet sleep [32].
The underlying mechanisms are unknown but there is
presumably some malfunction in the respiratory control if
breathing ceases during sleep, and if arousal and
hyperventilation do not occur despite the development of
asphyxia in these infants.
THE SUDDEN INFANT DEATH SYNDROME (SIDS)
Clinical and Epidemiological Features
Crib death or the Sudden Infant Death Syndrome (SIDS)
is the major cause of death in infants within the first year of
age [33]. According to the definition proposed by Beckwick
[34], SIDS is the sudden death of an infant or young child
which is unexpected in view of its medical history, and in
which a thorough postmortem examination fails to
demonstrate an adequate cause of death. This definition
implies that most diagnoses of SIDS are made postmortem,
and by exclusion. However, in the clinical history of infants
dying of SIDS it is common to find episodes of cyanosis and
apnea while the babies were quietly sleeping, and there are
vivid descriptions of “near misses” in which babies have
been resuscitated from episodes of prolonged apnea.
The cause of death in SIDS may be the result of multiple
determining factors, and of an interaction between
physiological and environmental elements. SIDS is rare in
babies less than 1 month and over 6 months of age, having a
peak incidence at 2-4 months of age. This epidemiological
fact might suggest that there is a particularly vulnerable stage
in the development of respiratory control between these ages
[35]. Infants with low weight at birth, or born prematurely,
are at increased risk of SIDS, as are infants of multiple births
and newborns of human newborns in comparison with other
animal orders [36]. The incidence of SIDS varies with the
season, with more deaths occurring during the winter
months, suggesting that there may be some infectious
component in triggering SIDS. Maternal risk factors include:
young maternal age, poor prenatal care, bleeding during
pregnancy, and smoking. Furthermore, there is evidence that
household exposure to tobacco smoke has an independent
additive effect [37,38]. Parental drug misuse (apart from
smoking) has an additional small but significant effect [39].
These and other environmental factors, such as infections for
example, may act in combination with a vulnerable stage of
physiological development, to precipitate death [40].
SIDS is closely associated with sleep. The relationship
between SIDS and the sleeping position has been examined
in several epidemiological studies. Most, but not all, of these
studies found that the prone position during sleep was more
common in babies dying of SIDS than in control babies. The
mechanism underlying the apparently significant association
between the prone position for sleep and the risk for SIDS is
unknown, but impaired ventilatory control and arousal
responsiveness have been suggested [41].
Peripheral Chemoreceptors and SIDS
Several hypotheses have proposed the implication of a
defective function of the peripheral chemoreceptors in the
etiology of SIDS28,42. Over the last 30 years, the morphology
of the carotid body has been addressed in several studies on
SIDS. In general, however, the findings have been
conflicting. Naeye et al. found abnormally increased or
abnormally decreased amounts of glomic tissue to be
present, the former being more prominent in victims with
more severe antecedent chronic hypoxia [42]. Lack et al.
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observed that the carotid body combined weights were
slightly heavier in SIDS cases, but computerized planimetry
of the total surface area and the area occupied by “functional
parenchyma” revealed no significant differences between
SIDS victims and controls41. Furthermore, the chief cells
showed a similarly intense degree of cytoplasmic
argyrophilia in both groups [42] and ultrastructural studies
yielded contradictory results [43-45]. Although these data
did not support a significant role for the carotid body in the
pathogenesis of SIDS, further investigation of this issue is
warranted.
The specific function of the vagal body paraganglia,
located at various points along the peripheral distribution of
the vagus nerve, is still unclear [6]. These consist of small
groups of glomic tissue, typically situated inside the
perineurium, just beneath the nerve sheath or between nerve
fibers, which cannot be microscopically or cytochemically
distinguished from the other peripheral chemoreceptors [46].
Hyperplasia of the vagal body paraganglia has been noted in
patients with chronic hypoxemia, supporting a
chemoreceptor function for this neuroendocrine tissue [47].
In SIDS, no significant microanatomic differences have been
reported compared with controls, but an underlying
functional abnormality with autonomic dysfunction cannot
be excluded [46].
Located within the epithelial lining of the pulmonary
airways, the neuroepithelial bodies are considered
intrapulmonary chemoreceptors. Compensatory hyperplasia
of the neuroepithelial bodies has been described in the lungs
of SIDS victims, characterized by an increase in the
frequency, size and mean concentration of bombesin-like
peptides of the neuroepithelial cells, when compared to the
values in age-matched controls [48,49]. Furthermore, the
frequency and size of pulmonary neuroepithelial bodies
immunostained for bombesin was increased twofold in two
cases of the congenital central hypoventilation syndrome, a
rare disorder of unknown etiology characterized by failure of
respiratory control [50]. Since neuroepithelial bodies are
thought to function as hypoxia-sensitive airway
chemoreceptors, it has been speculated that chronic hypoxia
and/or brainstem dysfunction may be responsible for this
alteration, contributing to the pathophysiology of SIDS and
related conditions such as the congenital central
hypoventilation syndrome [48-50].
Enlargement of the aorticopulmonary paraganglia has
been described in some infants who died of SIDS [28,51,52].
This alteration, present in 24% of SIDS cases, can easily be
inferred from sections under a low power microscope lens,
as shown in (Fig. 1), nevertheless, unequivocal proof of
glomic cell proliferation can only be gained by
morphometrical measurement. The normal appearance of a
few, small, discrete lobules separate from the fibroadipose
tissue is lost and individual lobules show great enlargement
with irregular and elongated profiles. The enlargement of the
aorticopulmonary paraganglia is due in a small part to an
increase in the number of lobules but more importantly, to an
increase in size of the lobules. The cell clusters and cell
diameters have not been found to be significantly different
from those in age-matched controls, thus enlargement of the
aorticopulmonary paraganglia involves an increase in the
number rather than the size of cells, favoring hyperplasia
rather than hypertrophy [28].
Previous reports had described a more extensive and
prominent distribution of paraganglion cells in the human
fetus and in newborn infants than in adults [6,53]. Our
studies have confirmed this finding [28]. The
aorticopulmonary paraganglia were more developed in
controls at birth and decreased dramatically during the first
year of life. The mechanisms underlying this morphologic
variation are not yet known [54]. This normal “shaping or
molding” with age was not observed in the SIDS group. The
aorticopulmonary paraganglia volumes in these cases
appeared to be already increased in the younger group and
remained practically unaltered at all age intervals, suggesting
that the stimulus to proliferate (hypoxia, trauma or irritation)
could be produced or initiated during fetal development or in
the early postnatal period. This stimulus could produce
structural and/or functional alterations in the chemoreceptor
cascade in the late-term fetus or newborn infant, preventing
them from responding promptly to chemical stimuli [28].
Final Comments
The core of the SIDS physiopathology is attributed to
impaired developmental processes in chemoreceptors,
including their neurotransmitter systems, in both the
peripheral and the central nervous system. Some
environmental factors have a well-established role in the
genesis of such alterations. At the functional level, SIDS
implies a defective resetting (slow or incomplete) of the
sensitivity to hypoxia and hypercapnia and/or a defective
processing of signals in the cardiorespiratory centers of the
brainstem. A normal infant’s nervous system receives
prompt information on a progressive hypercapnia and
hypoxia event, and triggers a new respiration or arousal; in
infants with peripheral or central chemoreception defects
these protective reflexes are not initiated at normal levels of
hypoxia and hypercapnia, and prolonged apnea can develop
until blood gas alterations reach the higher level required to
initiate the new respiration or arousal. These prolonged
apnea may lead to fatal apnea and sudden death.
On the other hand, some victims of SIDS present higher
iron concentrations in the liver than those in normal
newborns [55]. It is not presently known whether the
increase in blood iron and ferritin concentrations is a cause
or an effect (or is an unrelated finding) of abnormal oxygen
management, including altered sensitivity to low oxygen.
These findings suggest the possibility that in SIDS cases,
regardless of the quality of the central nervous system, the
final effectors of respiratory output might be too inefficient
to respond. However, whether these alterations are unique or
primary in triggering SIDS is not known.
In conclusion, it is important to submit every case of
sudden unexpected infant death to complete and accurate
post mortem investigation, including close study of the
peripheral chemoreceptors. In fact, the current definition of
SIDS as “the sudden death of an infant under one year of age
which remains unexplained after a thorough case investigation,
including performance of a complete autopsy, examination
of the death scene, and review of the clinical history” needs
to be amplified, to include “complete autopsy examination
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with an in-depth histopathological analysis of the autonomic
nervous system and of the cardiac conduction system
performed by an experienced, reliable pathologist” [56].
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